Latest filing published 16 Jul 2015 for Nexvet Biopharma plc, €411.
Insider track record
No signal scores available.
Graeme Wald: trading record in brief
Graeme Wald discloses dealings in Nexvet Biopharma plc to SEC (Form 4). Over a trading history stretching from 10 February 2015 to 15 July 2015, the count stands at 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 16 July 2015 came the latest disclosure, an option exercise for €411 in Nexvet Biopharma plc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Graeme Wald
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,600 shares@ US$0.125Ordinary SharesSEC:0001572426-15-000080:0
- 6,176 sharesOrdinary SharesSEC:0001632388-15-000006:0
- 7,548 sharesOrdinary SharesSEC:0001632388-15-000006:1
3 of 3 declarations